Gastroesophageal Junction Adenocarcinoma
1 competing product in clinical development for Gastroesophageal Junction Adenocarcinoma.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Ramucirumab + Paclitaxel + Placebo | Eli Lilly | Phase 3 | Completed | 77 |